Neutrophils induced licensing of natural killer cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Amano, Keishiro ^a   Hirayama, Masahiro ^a   Azuma, Eiichi ^a   Iwamoto, Shotaro ^a   Keida, Yoshitaka ^a   Komada, Yoshihiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM;

CYTOMEGALOVIRUS; MURINAE; MUS;

ANIMALS; FEMALE; FLOW CYTOMETRY; INJECTIONS, INTRAPERITONEAL; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MICE; MICE, INBRED C57BL; NEUTROPHILS;

EID: 84929377439     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/747680     Document Type: Article

References (22)

1. L. Vago, B. Forno, M. P. Sormani et al., "Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation," Blood, vol. 112, no. 8, pp. 3488-3499, 2008.
2. L. Ruggeri,M. Capanni, E. Urbani et al., "Effectiveness of donor natural killer cell aloreactivity in mismatched hematopoietic transplants," Science, vol. 295, no. 5562, pp. 2097-2100, 2002.
3. A. Antoun, D. Vekaria, R. A. Salama et al., "The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stemcell transplantation," British Journal of Haematology, vol. 159, no. 5, pp. 589-598, 2012.
4. B. Foley, S. Cooley, M. R. Verneris et al., "Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function," Blood, vol. 119, no. 11, pp. 2665-2674, 2012.
5. J. C. Sun, J. N. Beilke, and L. L. Lanier, "Adaptive immune features of natural killer cells," Nature, vol. 457, pp. 557-561, 2009.
6. P. Ljungman, L. Perez-Bercoff, J. Jonsson et al., "Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation," Haematologica, vol. 91, no. 1, pp. 78-83, 2006.
7. M. Schmidt-Hieber, M. Labopin, D. Beelen et al., "CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT," Blood, vol. 122, no. 19, pp. 3359-3364, 2013.
8. B.N. Jaeger, J.Donadieu, C. Cognet et al., "Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis," The Journal of Experimental Medicine, vol. 209, no. 3, pp. 565-580, 2012.
9. S. Kim, J. Poursine-Laurent, S. M. Truscott et al., "Licensing of natural killer cells by host major histocompatibility complex class I molecules," Nature, vol. 436, no. 7051, pp. 709-713, 2005.
10. M. Hirayama, E. Azuma, Q. Jiang et al., "The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation," British Journal of Haematology, vol. 111, no. 2, pp. 700-707, 2000.
11. M. Araki, M. Hirayama, E. Azuma et al., "Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model," Journal of Immunology, vol. 185, no. 12, pp. 7739-7745, 2010.
12. K. K. Hyun, M. De La Luz Sierra, C. K.Williams, A. V. Gulino, and G. Tosato, "G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells," Blood, vol. 108, no. 3, pp. 812-820, 2006.
13. J. R. Ortaldo, A. T. Mason, R. Winkler-Pickett, A. Raziuddin, W. J. Murphy, and L. H. Mason, "Ly-49 receptor expression and functional analysis in multiple mouse strains," Journal of Leukocyte Biology, vol. 66, no. 3, pp. 512-520, 1999.
14. T. A. Springer, "Traffic signals for lymphocyte recirculation and leukocyte emigration: themultistep paradigm," Cell, vol. 76, no. 2, pp. 301-314, 1994.
15. M. T. L. Castelo-Branco, I. D. P. Soares, D. V. Lopes et al., "Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis," PLoS ONE, vol. 7, no. 3,Article IDe33360, 2012.
16. J. M. Elliott, J. A. Wahle, and W. M. Yokoyama, "MHC class Ideficient natural killer cells acquire a licensed phenotype after transfer into anMHC class I-sufficient environment," Journal of Experimental Medicine, vol. 207, no. 10, pp. 2073-2079, 2010.
17. C.Costantini, A.Micheletti,F.Calzetti,O. Perbellini, G. Pizzolo, and M. A. Cassatella, "Neutrophil activation and survival are modulated by interaction with NK cells," International Immunology, vol. 22, no. 10, pp. 827-838, 2010.
18. C. Costantini, A. Micheletti, F. Calzetti et al., "On the potential involvement of CD11d in co-stimulating the production of interferon-α by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3," Haematologica, vol. 96, no. 10, pp. 1543-1547, 2011.
19. E. Barker and R. A. Reisfeld, "A mechanism for neutrophilmediated lysis of human neuroblastoma cells," Cancer Research, vol. 53, no. 2, pp. 362-367, 1993.
20. A. L. Gilman, F. M. Ozkaynak, K. K. Matthay et al., "Phase I study of ch 14.18 with granulocyte-macrophage colonystimulating factor and interleukin-2 in children with neuroblastoma after autologous bonemarrow transplantation or stemcell rescue: a report from the children's oncology group," Journal of Clinical Oncology, vol. 27, no. 1, pp. 85-91, 2009.
21. I. Y. Cheung, K. Hsu, and N. K. V. Cheung, "Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colonystimulating factor," Journal of Clinical Oncology, vol. 30, no. 4, pp. 426-432, 2012.
22. L. Willems, S. Fevery, B. Sprangers et al., "Recipient leukocyte infusion enhances the local and systemic graft-versusneuroblastoma effect of allogeneic bone marrow transplantation in mice," Cancer Immunology, Immunotherapy, vol. 62, no. 11, pp. 1733-1744, 2013.